[Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam)

May 29, 2026 (Submission deadline for RFP ALNY-RFP-TTR-13)

Up to $250,000 per proposal; multiple awards possible; actual award may be less than requested.

Supports independent educational projects to improve clinical decision-making in transthyretin-mediated amyloidosis (ATTR-CM).

Only organizations (not individuals) may apply; ACCME accreditation required for medical education providers.

--- ## Description Alnylam Pharmaceuticals is offering grant support for independent educational initiatives focused on advancing clinical decision-making in transthyretin-mediated amyloidosis (ATTR-CM). This opportunity (RFP ALNY-RFP-TTR-13) seeks proposals that address persistent gaps in screening, diagnosis, monitoring, and management of ATTR-CM, with a strong emphasis on practical, real-world application for healthcare professionals. Supported projects should equip clinicians with actionable tools and frameworks that can be readily implemented in routine practice, ultimately aiming to improve patient outcomes. Funding is available for activities such as symposia, digital education, and live regional programs, and content must be grounded in peer-reviewed evidence, free from commercial bias, and designed for broad dissemination. --- ## Due Dates - May 29, 2026: Submission deadline for RFP ALNY-RFP-TTR-13 (Advancing Clinical Decision-Making in ATTR-CM) --- ## Funding Amount - Individual proposals may receive up to **$250,000 USD**. - Multiple awards are possible, including for different venues or channels. - The awarded amount may be less than requested; applicants are encouraged to seek multiple sources of support. - Budget must be detailed, reasonable, and within fair market value; grant funds may not be used for meals for attendee HCPs. --- ## Eligibility - **Eligible applicants:** - Professional associations - Patient advocacy organizations - Healthcare institutions - Medical education companies - Other organizations committed to healthcare improvement - **Ineligible applicants:** - Individuals - Healthcare provider practice groups or clinics - Managed care organizations - Pharmacy benefit managers - **Accreditation:** - Medical education providers must be ACCME-accredited; the requestor must be the accredited provider. - Activities must comply with all relevant accreditation standards and regulations. --- ## Application Process - Submit proposals electronically through the [Alnylam grants portal](https://alnylam-grants.steeprockinc.com) or via the [Alnylam Grants and Giving page](https://www.alnylam.com/about-alnylam/grants-and-giving). - Proposals must include: - Comprehensive gap analysis/needs assessment - Identification of barriers to practice change - Description of target audience and recruitment methods - SMART learning objectives - Overview of content and educational design - Faculty recruitment and qualifications - Evaluation and outcomes reporting plan - Detailed budget and allocation of funds - Proof of accreditation status - Conflict of interest and disclosure policies - Plans for dissemination and sustainability - Honoraria and reimbursement policies - Project timeline - All requests must be submitted in English and at least 45 days prior to program start date. - Notification of award decisions will be sent by June 12, 2026. --- ## Additional Information - Proposals may target U.S. and/or global audiences, with a focus on specialists involved in ATTR-CM management (e.g., cardiologists, clinical pharmacists). - Educational content should be practical, evidence-based, and accessible, with enduring materials for ongoing use. - The preferred launch date for educational content is August 2026. - Alnylam may request additional information during review; incomplete applications may be rejected. - All funded activities must comply with transparency laws and reporting requirements. --- ## External Links - [Alnylam Grants and Giving Program Overview](https://www.alnylam.com/about-alnylam/grants-and-giving#charitable-donations) - [RFP ALNY-RFP-TTR-13 Details (PDF)](https://www.alnylam.com/sites/default/files/pdfs/ALNY-RFP-TTR-13%20Advancing%20Clinical%20Decision-Making%20in%20ATTR-CM.pdf) - [Alnylam Grants Submission Portal](https://alnylam-grants.steeprockinc.com) - [Alnylam Investigator-Initiated Studies](https://www.alnylam.com/about-alnylam/investigator-initiated-studies/) --- ## Contact Information | Purpose | Contact | |--------------------------|---------------------------------------------| | General grant inquiries | [grants@alnylam.com](mailto:grants@alnylam.com) | | Alnylam contact page | [Contact Alnylam](https://www.alnylam.com/contact) |

Grants and Giving

Sign in to see full grant listing